At Lundbeck, we are tirelessly dedicated to restoring brain health, so every person can be their best. For more than 70 years, we have been at the forefront of brain research, delivering breakthrough therapies to millions of people worldwide. Based in Copenhagen with U.S. headquarters in Deerfield, we are uncompromisingly committed to developing and providing innovative treatments for brain disorders – even as other pharmaceutical companies abandon this challenging space. In fact, we are the only global biopharmaceutical company solely focused on the brain. We are majority-owned by the Lundbeck Foundation, a non-profit research foundation, and our unique ownership model distinguishes us from other biopharmaceutical companies and binds our corporate purpose to brain research.
At Lundbeck, we always see the person behind the disease. We have deep connections with our patient communities and our colleagues regularly participate in advocacy events around Chicago, demonstrating (on their own time) their passion for supporting patients and communities affected by brain disease.